<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">D'Angelo, Sandra P</style></author><author><style face="normal" font="default" size="100%">Bhatia, Shailender</style></author><author><style face="normal" font="default" size="100%">Brohl, Andrew S</style></author><author><style face="normal" font="default" size="100%">Hamid, Omid</style></author><author><style face="normal" font="default" size="100%">Mehnert, Janice M</style></author><author><style face="normal" font="default" size="100%">Terheyden, Patrick</style></author><author><style face="normal" font="default" size="100%">Shih, Kent C</style></author><author><style face="normal" font="default" size="100%">Brownell, Isaac</style></author><author><style face="normal" font="default" size="100%">Lebbé, Celeste</style></author><author><style face="normal" font="default" size="100%">Lewis, Karl D</style></author><author><style face="normal" font="default" size="100%">Linette, Gerald P</style></author><author><style face="normal" font="default" size="100%">Milella, Michele</style></author><author><style face="normal" font="default" size="100%">Georges, Sara</style></author><author><style face="normal" font="default" size="100%">Shah, Parantu</style></author><author><style face="normal" font="default" size="100%">Ellers-Lenz, Barbara</style></author><author><style face="normal" font="default" size="100%">Bajars, Marcis</style></author><author><style face="normal" font="default" size="100%">Güzel, Gülseren</style></author><author><style face="normal" font="default" size="100%">Nghiem, Paul T</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial</style></title><secondary-title><style face="normal" font="default" size="100%">Journal for ImmunoTherapy of Cancer</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2020-05-01 00:00:00</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">e000674</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.1136/jitc-2020-000674</style></doi><volume><style face="normal" font="default" size="100%">8</style></volume><issue><style face="normal" font="default" size="100%">1</style></issue><abstract><style  face="normal" font="default" size="100%">Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.</style></abstract></record></records></xml>